ATE232850T1 - Tetrahydroisoquinoline derivate als modulatoren von dopamine d3 rezeptoren - Google Patents

Tetrahydroisoquinoline derivate als modulatoren von dopamine d3 rezeptoren

Info

Publication number
ATE232850T1
ATE232850T1 AT97923065T AT97923065T ATE232850T1 AT E232850 T1 ATE232850 T1 AT E232850T1 AT 97923065 T AT97923065 T AT 97923065T AT 97923065 T AT97923065 T AT 97923065T AT E232850 T1 ATE232850 T1 AT E232850T1
Authority
AT
Austria
Prior art keywords
dopamine
modulators
receptors
tetrahydroisoquinoline derivatives
tetrahydroisoquinoline
Prior art date
Application number
AT97923065T
Other languages
English (en)
Inventor
Geoffrey Stemp
Amanda Johns
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9609888.4A external-priority patent/GB9609888D0/en
Priority claimed from GBGB9617189.7A external-priority patent/GB9617189D0/en
Priority claimed from GBGB9704490.3A external-priority patent/GB9704490D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE232850T1 publication Critical patent/ATE232850T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AT97923065T 1996-05-11 1997-05-06 Tetrahydroisoquinoline derivate als modulatoren von dopamine d3 rezeptoren ATE232850T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9609888.4A GB9609888D0 (en) 1996-05-11 1996-05-11 Compounds
GBGB9617189.7A GB9617189D0 (en) 1996-08-16 1996-08-16 Compounds
GBGB9704490.3A GB9704490D0 (en) 1997-03-05 1997-03-05 Compounds
PCT/EP1997/002434 WO1997043262A1 (en) 1996-05-11 1997-05-06 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors

Publications (1)

Publication Number Publication Date
ATE232850T1 true ATE232850T1 (de) 2003-03-15

Family

ID=27268278

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97923065T ATE232850T1 (de) 1996-05-11 1997-05-06 Tetrahydroisoquinoline derivate als modulatoren von dopamine d3 rezeptoren

Country Status (18)

Country Link
US (1) US6046210A (de)
EP (1) EP0917530B1 (de)
JP (1) JP2000510137A (de)
KR (1) KR20000010905A (de)
AR (1) AR007077A1 (de)
AT (1) ATE232850T1 (de)
AU (1) AU2897497A (de)
BR (1) BR9709220A (de)
CA (1) CA2253927A1 (de)
CZ (1) CZ363298A3 (de)
DE (1) DE69719191T2 (de)
ES (1) ES2191838T3 (de)
IL (1) IL126747A0 (de)
NO (1) NO985242L (de)
NZ (1) NZ332477A (de)
PL (1) PL329803A1 (de)
TR (1) TR199802284T2 (de)
WO (1) WO1997043262A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69704060T2 (de) * 1996-08-14 2001-08-02 Smithkline Beecham P.L.C., Brentford Tetrahydroisochinolinderivate und ihre pharmazeutische anwendung
GB9708694D0 (en) * 1997-04-30 1997-06-18 Smithkline Beecham Plc Compounds
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
PL336628A1 (en) * 1997-05-03 2000-07-03 Smithkline Beecham Plc Derivatives of tetrahydroisoquinoline as modulators of d3 dopamine receptors
GB9709303D0 (en) * 1997-05-09 1997-06-25 Smithkline Beecham Plc Compounds
TW450954B (en) * 1998-05-14 2001-08-21 Pharmacia & Amp Upjohn Company Phenylsulfonamide-phenylethylamines useful as dopamine receptors
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
GB9812522D0 (en) * 1998-06-10 1998-08-05 Smithkline Beecham Plc Compounds
GB9821977D0 (en) * 1998-10-08 1998-12-02 Smithkline Beecham Plc Compounds
SK4782001A3 (en) * 1998-10-08 2001-11-06 Smithkline Beecham Plc Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
GB9821978D0 (en) 1998-10-08 1998-12-02 Smithkline Beecham Plc Compounds
TWI274750B (en) 1999-01-12 2007-03-01 Abbott Gmbh & Co Kg Triazole compounds showing high affinity to dopamine D3 receptor and pharmaceutical composition comprising the same
AR038420A1 (es) 2002-02-15 2005-01-12 Glaxo Group Ltd Compuesto de amida, procedimiento para la preparacion del mismo, su uso para la fabricacion de un medicamento y composicion farmaceutica que lo comprende
MY133587A (en) 2002-05-29 2007-11-30 Glaxo Group Ltd Aromatic sulfones and their medical use
US7659400B2 (en) * 2003-07-31 2010-02-09 Washington University Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging
EP1660137A4 (de) * 2003-07-31 2008-11-12 Univ St Louis Sigma-2-rezeptor-radiotracer zur bilddarstellung des proliferationsstatus von soliden tumoren
BRPI0511993A (pt) * 2004-07-20 2008-01-22 Siena Biotech Spa compostos moduladores de receptores de acetilcolina nicotìnicos alfa7, composições farmacêuticas e usos terapêuticos dos mesmos
EP2527337A1 (de) * 2005-04-14 2012-11-28 Bristol-Myers Squibb Company Hemmer des 11-Beta-Hydroxysteroid-Dehydrogenase-1-Enzyms
TW200901974A (en) 2007-01-16 2009-01-16 Wyeth Corp Compounds, compositions, and methods of making and using them
JP5701213B2 (ja) 2008-10-10 2015-04-15 インスティチュート オブ ファーマコロジー アンド トキシコロジー アカデミー オブ ミリタリー メディカル サイエンシズ ピー.エル.エー.チャイナ 新規なドーパミンd3受容体リガンド、その調製及び使用
US9227944B2 (en) 2008-10-10 2016-01-05 Institute Of Pharmacology And Toxicology Academy Of Military Science P.L.A. China Dopamine D3 receptor ligands and preparation and medical uses of the same
EP3189041B1 (de) 2014-09-03 2021-04-28 Ctxt Pty Ltd Vom tetrahydroisochinolin abgeleitete prmt5-inhibitoren
WO2016034671A1 (en) 2014-09-03 2016-03-10 Ctxt Pty Ltd Aminoindane-, aminotetrahydronaphthalene- and aminobenzocyclobutane-derived prmt5-inhibitors
GB201415573D0 (en) 2014-09-03 2014-10-15 Cancer Therapeutics Crc Pty Ltd Compounds
GB201604022D0 (en) 2016-03-09 2016-04-20 Ctxt Pty Ltd Compounds
GB201604027D0 (en) 2016-03-09 2016-04-20 Ctxt Pty Ltd Compounds
GB201604029D0 (en) 2016-03-09 2016-04-20 Ctxt Pty Ltd Compounds
GB201604030D0 (en) 2016-03-09 2016-04-20 Ctxt Pty Ltd Compounds
GB201604020D0 (en) 2016-03-09 2016-04-20 Ctxt Pty Ltd Compounds
GB201604031D0 (en) 2016-03-09 2016-04-20 Ctxt Pty Ltd Compounds
WO2018021447A1 (ja) 2016-07-28 2018-02-01 塩野義製薬株式会社 ドーパミンd3受容体拮抗作用を有する含窒素縮環化合物
BR112020014875A2 (pt) 2018-01-26 2020-12-08 Shionogi & Co., Ltd. Composto cíclico condensado tendo antagonismo de receptor de dopamina d3

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294621A (en) * 1992-10-07 1994-03-15 Ortho Pharmaceutical Corporation Thieno tetrahydropyridines useful as class III antiarrhythmic agents
DE4425146A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen

Also Published As

Publication number Publication date
BR9709220A (pt) 1999-08-10
DE69719191T2 (de) 2003-11-27
NZ332477A (en) 2000-07-28
EP0917530A1 (de) 1999-05-26
AU2897497A (en) 1997-12-05
EP0917530B1 (de) 2003-02-19
IL126747A0 (en) 1999-08-17
DE69719191D1 (de) 2003-03-27
NO985242D0 (no) 1998-11-10
AR007077A1 (es) 1999-10-13
WO1997043262A1 (en) 1997-11-20
PL329803A1 (en) 1999-04-12
KR20000010905A (ko) 2000-02-25
CA2253927A1 (en) 1997-11-20
CZ363298A3 (cs) 1999-06-16
TR199802284T2 (xx) 2000-05-22
JP2000510137A (ja) 2000-08-08
US6046210A (en) 2000-04-04
ES2191838T3 (es) 2003-09-16
NO985242L (no) 1998-12-09

Similar Documents

Publication Publication Date Title
DE69719191D1 (de) Tetrahydroisoquinoline derivate als modulatoren von dopamine d3 rezeptoren
DE69605430D1 (de) Chinolin-2-on derivate als serotonin antagonisten
NO995338D0 (no) Tetrahydroisokinolinderivater som modulatorer for dopamin-D3-reseptorer
DE69813616D1 (de) Cyclohexencarboxylate als inhibitoren der neuraminidase
DE69712331D1 (de) Pyrimidin-4-on derivate als pestizidesmittel
DE69628334D1 (de) Chinolin derivate als nk3 antagoniste
DE69401823D1 (de) Indolin derivate als 5ht2c antagonisten
DE69723446D1 (de) Oxindole derivate
PT1001934E (pt) Compostos de indole como inibidores de cox-2
DE69841138D1 (de) Imidazolderivate als mdr-modulatoren
PT1036072E (pt) Antagonistas de receptores de trombina
ATE221052T1 (de) Tetrahydrochinolinderivate als eaa antagonisten
DE69819903D1 (de) Bizyklische verbindungen als liganden der 5-ht1 rezeptoren
ATE240943T1 (de) Isochinolin derivate als urokinase inhibitoren
PT696194E (pt) Utilizacao de derivados de indole como antagonistas de 5ht1
ATE254621T1 (de) Thienoisoxazolyl- und thienylpyrazolyl-phenoxy substituierte propyl derivate als d4 antagonisten
DE69703242D1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
DE69803689D1 (de) 8-azabicyclo(3.2.1)0ctan-3-methanaminderivate als liganden der dopamin-rezeptoren d2 und d3 und der serotonin-rezeptoren 5ht1a und 5ht2
DE69735811D1 (de) Piperazinoderivate als neurokinin-antagonisten
EE9800281A (et) Kondenseeritud imidasoolderivaadid multiravimiresistentsi moduleerijatena
DE69717449D1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
DE69903627D1 (de) Tetrahydroisochinolinderivate als modulatoren von dopamin d3 rezeptoren
DE69617010D1 (de) Isazole derivate als fibrinogen-rezeptor-antagonisten
DE60023020D1 (de) Positive modulatoren von nicotinrezeptor-agonisten
DE69710305D1 (de) Derivate von 4-Vinyl-4'-alpha-hydroxyethyl-biphenyl

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties